Due to the COVID-19 pandemic, the global Respiratory Inhaler Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Dry Powder Inhaler accounting for % of the Respiratory Inhaler Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Asthma segment is altered to an % CAGR throughout this forecast period.

China Respiratory Inhaler Devices market size is valued at US$ million in 2021, while the US and Europe Respiratory Inhaler Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Respiratory Inhaler Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Respiratory Inhaler Devices include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V. and PARI Medical Holding and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Respiratory Inhaler Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Respiratory Inhaler Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

By Type

Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer

By Application

Asthma
COPD
Pulmonary Arterial Hypertension
Others Respiratory Disease

By Companies

AstraZeneca
Beximco Pharmaceuticals Ltd.
Boehringer Ingelheim GmbH
Cipla Ltd.
GlaxoSmithKline plc
Koninklijke Philips N.V.
Merck & Co., Inc.
OMRON Healthcare Europe B.V.
PARI Medical Holding
Teva Pharmaceutical Industries Ltd

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

1 Study Coverage

1.1 Respiratory Inhaler Devices Product Introduction

1.2 Market by Type

1.2.1 Global Respiratory Inhaler Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Dry Powder Inhaler

1.2.3 Metered Dose Inhaler

1.2.4 Nebulizer

1.3 Market by Application

1.3.1 Global Respiratory Inhaler Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Asthma

1.3.3 COPD

1.3.4 Pulmonary Arterial Hypertension

1.3.5 Others Respiratory Disease

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Respiratory Inhaler Devices Sales Estimates and Forecasts 2017-2028

2.2 Global Respiratory Inhaler Devices Revenue Estimates and Forecasts 2017-2028

2.3 Global Respiratory Inhaler Devices Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Respiratory Inhaler Devices Sales by Region

2.4.1 Global Respiratory Inhaler Devices Sales by Region (2017-2022)

2.4.2 Global Sales Respiratory Inhaler Devices by Region (2023-2028)

2.5 Global Respiratory Inhaler Devices Revenue by Region

2.5.1 Global Respiratory Inhaler Devices Revenue by Region (2017-2022)

2.5.2 Global Respiratory Inhaler Devices Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Respiratory Inhaler Devices Sales by Manufacturers

3.1.1 Global Top Respiratory Inhaler Devices Manufacturers by Sales (2017-2022)

3.1.2 Global Respiratory Inhaler Devices Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Respiratory Inhaler Devices in 2021

3.2 Global Respiratory Inhaler Devices Revenue by Manufacturers

3.2.1 Global Respiratory Inhaler Devices Revenue by Manufacturers (2017-2022)

3.2.2 Global Respiratory Inhaler Devices Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Respiratory Inhaler Devices Revenue in 2021

3.3 Global Respiratory Inhaler Devices Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Respiratory Inhaler Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Respiratory Inhaler Devices Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Respiratory Inhaler Devices Sales by Type

4.1.1 Global Respiratory Inhaler Devices Historical Sales by Type (2017-2022)

4.1.2 Global Respiratory Inhaler Devices Forecasted Sales by Type (2023-2028)

4.1.3 Global Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

4.2 Global Respiratory Inhaler Devices Revenue by Type

4.2.1 Global Respiratory Inhaler Devices Historical Revenue by Type (2017-2022)

4.2.2 Global Respiratory Inhaler Devices Forecasted Revenue by Type (2023-2028)

4.2.3 Global Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

4.3 Global Respiratory Inhaler Devices Price by Type

4.3.1 Global Respiratory Inhaler Devices Price by Type (2017-2022)

4.3.2 Global Respiratory Inhaler Devices Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Respiratory Inhaler Devices Sales by Application

5.1.1 Global Respiratory Inhaler Devices Historical Sales by Application (2017-2022)

5.1.2 Global Respiratory Inhaler Devices Forecasted Sales by Application (2023-2028)

5.1.3 Global Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

5.2 Global Respiratory Inhaler Devices Revenue by Application

5.2.1 Global Respiratory Inhaler Devices Historical Revenue by Application (2017-2022)

5.2.2 Global Respiratory Inhaler Devices Forecasted Revenue by Application (2023-2028)

5.2.3 Global Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

5.3 Global Respiratory Inhaler Devices Price by Application

5.3.1 Global Respiratory Inhaler Devices Price by Application (2017-2022)

5.3.2 Global Respiratory Inhaler Devices Price Forecast by Application (2023-2028)

6 North America

6.1 North America Respiratory Inhaler Devices Market Size by Type

6.1.1 North America Respiratory Inhaler Devices Sales by Type (2017-2028)

6.1.2 North America Respiratory Inhaler Devices Revenue by Type (2017-2028)

6.2 North America Respiratory Inhaler Devices Market Size by Application

6.2.1 North America Respiratory Inhaler Devices Sales by Application (2017-2028)

6.2.2 North America Respiratory Inhaler Devices Revenue by Application (2017-2028)

6.3 North America Respiratory Inhaler Devices Market Size by Country

6.3.1 North America Respiratory Inhaler Devices Sales by Country (2017-2028)

6.3.2 North America Respiratory Inhaler Devices Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Respiratory Inhaler Devices Market Size by Type

7.1.1 Europe Respiratory Inhaler Devices Sales by Type (2017-2028)

7.1.2 Europe Respiratory Inhaler Devices Revenue by Type (2017-2028)

7.2 Europe Respiratory Inhaler Devices Market Size by Application

7.2.1 Europe Respiratory Inhaler Devices Sales by Application (2017-2028)

7.2.2 Europe Respiratory Inhaler Devices Revenue by Application (2017-2028)

7.3 Europe Respiratory Inhaler Devices Market Size by Country

7.3.1 Europe Respiratory Inhaler Devices Sales by Country (2017-2028)

7.3.2 Europe Respiratory Inhaler Devices Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Respiratory Inhaler Devices Market Size by Type

8.1.1 Asia Pacific Respiratory Inhaler Devices Sales by Type (2017-2028)

8.1.2 Asia Pacific Respiratory Inhaler Devices Revenue by Type (2017-2028)

8.2 Asia Pacific Respiratory Inhaler Devices Market Size by Application

8.2.1 Asia Pacific Respiratory Inhaler Devices Sales by Application (2017-2028)

8.2.2 Asia Pacific Respiratory Inhaler Devices Revenue by Application (2017-2028)

8.3 Asia Pacific Respiratory Inhaler Devices Market Size by Region

8.3.1 Asia Pacific Respiratory Inhaler Devices Sales by Region (2017-2028)

8.3.2 Asia Pacific Respiratory Inhaler Devices Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Respiratory Inhaler Devices Market Size by Type

9.1.1 Latin America Respiratory Inhaler Devices Sales by Type (2017-2028)

9.1.2 Latin America Respiratory Inhaler Devices Revenue by Type (2017-2028)

9.2 Latin America Respiratory Inhaler Devices Market Size by Application

9.2.1 Latin America Respiratory Inhaler Devices Sales by Application (2017-2028)

9.2.2 Latin America Respiratory Inhaler Devices Revenue by Application (2017-2028)

9.3 Latin America Respiratory Inhaler Devices Market Size by Country

9.3.1 Latin America Respiratory Inhaler Devices Sales by Country (2017-2028)

9.3.2 Latin America Respiratory Inhaler Devices Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Respiratory Inhaler Devices Market Size by Type

10.1.1 Middle East and Africa Respiratory Inhaler Devices Sales by Type (2017-2028)

10.1.2 Middle East and Africa Respiratory Inhaler Devices Revenue by Type (2017-2028)

10.2 Middle East and Africa Respiratory Inhaler Devices Market Size by Application

10.2.1 Middle East and Africa Respiratory Inhaler Devices Sales by Application (2017-2028)

10.2.2 Middle East and Africa Respiratory Inhaler Devices Revenue by Application (2017-2028)

10.3 Middle East and Africa Respiratory Inhaler Devices Market Size by Country

10.3.1 Middle East and Africa Respiratory Inhaler Devices Sales by Country (2017-2028)

10.3.2 Middle East and Africa Respiratory Inhaler Devices Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Corporation Information

11.1.2 AstraZeneca Overview

11.1.3 AstraZeneca Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 AstraZeneca Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 AstraZeneca Recent Developments

11.2 Beximco Pharmaceuticals Ltd.

11.2.1 Beximco Pharmaceuticals Ltd. Corporation Information

11.2.2 Beximco Pharmaceuticals Ltd. Overview

11.2.3 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Beximco Pharmaceuticals Ltd. Recent Developments

11.3 Boehringer Ingelheim GmbH

11.3.1 Boehringer Ingelheim GmbH Corporation Information

11.3.2 Boehringer Ingelheim GmbH Overview

11.3.3 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Boehringer Ingelheim GmbH Recent Developments

11.4 Cipla Ltd.

11.4.1 Cipla Ltd. Corporation Information

11.4.2 Cipla Ltd. Overview

11.4.3 Cipla Ltd. Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Cipla Ltd. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Cipla Ltd. Recent Developments

11.5 GlaxoSmithKline plc

11.5.1 GlaxoSmithKline plc Corporation Information

11.5.2 GlaxoSmithKline plc Overview

11.5.3 GlaxoSmithKline plc Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 GlaxoSmithKline plc Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 GlaxoSmithKline plc Recent Developments

11.6 Koninklijke Philips N.V.

11.6.1 Koninklijke Philips N.V. Corporation Information

11.6.2 Koninklijke Philips N.V. Overview

11.6.3 Koninklijke Philips N.V. Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Koninklijke Philips N.V. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Koninklijke Philips N.V. Recent Developments

11.7 Merck & Co., Inc.

11.7.1 Merck & Co., Inc. Corporation Information

11.7.2 Merck & Co., Inc. Overview

11.7.3 Merck & Co., Inc. Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Merck & Co., Inc. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Merck & Co., Inc. Recent Developments

11.8 OMRON Healthcare Europe B.V.

11.8.1 OMRON Healthcare Europe B.V. Corporation Information

11.8.2 OMRON Healthcare Europe B.V. Overview

11.8.3 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 OMRON Healthcare Europe B.V. Recent Developments

11.9 PARI Medical Holding

11.9.1 PARI Medical Holding Corporation Information

11.9.2 PARI Medical Holding Overview

11.9.3 PARI Medical Holding Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 PARI Medical Holding Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 PARI Medical Holding Recent Developments

11.10 Teva Pharmaceutical Industries Ltd

11.10.1 Teva Pharmaceutical Industries Ltd Corporation Information

11.10.2 Teva Pharmaceutical Industries Ltd Overview

11.10.3 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Teva Pharmaceutical Industries Ltd Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Respiratory Inhaler Devices Industry Chain Analysis

12.2 Respiratory Inhaler Devices Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Respiratory Inhaler Devices Production Mode & Process

12.4 Respiratory Inhaler Devices Sales and Marketing

12.4.1 Respiratory Inhaler Devices Sales Channels

12.4.2 Respiratory Inhaler Devices Distributors

12.5 Respiratory Inhaler Devices Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Respiratory Inhaler Devices Industry Trends

13.2 Respiratory Inhaler Devices Market Drivers

13.3 Respiratory Inhaler Devices Market Challenges

13.4 Respiratory Inhaler Devices Market Restraints

14 Key Findings in The Global Respiratory Inhaler Devices Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim GmbH

Merck& Co. Inc

OMRON Healthcare Europe B.V

Beximco Pharmaceuticals Ltd.

Cipla Ltd

Astrazeneca plc

GlaxoSmithKline PLC

PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

Koninklijke Philips N V

Company

China

Teva Pharmaceutical Industries Ltd

Omron

PARI Medical Holding

List of Tables

Table 1. Global Respiratory Inhaler Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Dry Powder Inhaler

Table 3. Major Manufacturers of Metered Dose Inhaler

Table 4. Major Manufacturers of Nebulizer

Table 5. Global Respiratory Inhaler Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Respiratory Inhaler Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Respiratory Inhaler Devices Sales by Region (2017-2022) & (K Units)

Table 8. Global Respiratory Inhaler Devices Sales Market Share by Region (2017-2022)

Table 9. Global Respiratory Inhaler Devices Sales by Region (2023-2028) & (K Units)

Table 10. Global Respiratory Inhaler Devices Sales Market Share by Region (2023-2028)

Table 11. Global Respiratory Inhaler Devices Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global Respiratory Inhaler Devices Revenue Market Share by Region (2017-2022)

Table 13. Global Respiratory Inhaler Devices Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global Respiratory Inhaler Devices Revenue Market Share by Region (2023-2028)

Table 15. Global Respiratory Inhaler Devices Sales by Manufacturers (2017-2022) & (K Units)

Table 16. Global Respiratory Inhaler Devices Sales Share by Manufacturers (2017-2022)

Table 17. Global Respiratory Inhaler Devices Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global Respiratory Inhaler Devices Revenue Share by Manufacturers (2017-2022)

Table 19. Respiratory Inhaler Devices Price by Manufacturers (2017-2022) &(USD/Unit)

Table 20. Global Respiratory Inhaler Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Respiratory Inhaler Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Inhaler Devices as of 2021)

Table 22. Respiratory Inhaler Devices Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Respiratory Inhaler Devices Product Offered

Table 24. Date of Manufacturers Enter into Respiratory Inhaler Devices Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Respiratory Inhaler Devices Sales by Type (2017-2022) & (K Units)

Table 27. Global Respiratory Inhaler Devices Sales by Type (2023-2028) & (K Units)

Table 28. Global Respiratory Inhaler Devices Sales Share by Type (2017-2022)

Table 29. Global Respiratory Inhaler Devices Sales Share by Type (2023-2028)

Table 30. Global Respiratory Inhaler Devices Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global Respiratory Inhaler Devices Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global Respiratory Inhaler Devices Revenue Share by Type (2017-2022)

Table 33. Global Respiratory Inhaler Devices Revenue Share by Type (2023-2028)

Table 34. Respiratory Inhaler Devices Price by Type (2017-2022) & (USD/Unit)

Table 35. Global Respiratory Inhaler Devices Price Forecast by Type (2023-2028) & (USD/Unit)

Table 36. Global Respiratory Inhaler Devices Sales by Application (2017-2022) & (K Units)

Table 37. Global Respiratory Inhaler Devices Sales by Application (2023-2028) & (K Units)

Table 38. Global Respiratory Inhaler Devices Sales Share by Application (2017-2022)

Table 39. Global Respiratory Inhaler Devices Sales Share by Application (2023-2028)

Table 40. Global Respiratory Inhaler Devices Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global Respiratory Inhaler Devices Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global Respiratory Inhaler Devices Revenue Share by Application (2017-2022)

Table 43. Global Respiratory Inhaler Devices Revenue Share by Application (2023-2028)

Table 44. Respiratory Inhaler Devices Price by Application (2017-2022) & (USD/Unit)

Table 45. Global Respiratory Inhaler Devices Price Forecast by Application (2023-2028) & (USD/Unit)

Table 46. North America Respiratory Inhaler Devices Sales by Type (2017-2022) & (K Units)

Table 47. North America Respiratory Inhaler Devices Sales by Type (2023-2028) & (K Units)

Table 48. North America Respiratory Inhaler Devices Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America Respiratory Inhaler Devices Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America Respiratory Inhaler Devices Sales by Application (2017-2022) & (K Units)

Table 51. North America Respiratory Inhaler Devices Sales by Application (2023-2028) & (K Units)

Table 52. North America Respiratory Inhaler Devices Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America Respiratory Inhaler Devices Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America Respiratory Inhaler Devices Sales by Country (2017-2022) & (K Units)

Table 55. North America Respiratory Inhaler Devices Sales by Country (2023-2028) & (K Units)

Table 56. North America Respiratory Inhaler Devices Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America Respiratory Inhaler Devices Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe Respiratory Inhaler Devices Sales by Type (2017-2022) & (K Units)

Table 59. Europe Respiratory Inhaler Devices Sales by Type (2023-2028) & (K Units)

Table 60. Europe Respiratory Inhaler Devices Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe Respiratory Inhaler Devices Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe Respiratory Inhaler Devices Sales by Application (2017-2022) & (K Units)

Table 63. Europe Respiratory Inhaler Devices Sales by Application (2023-2028) & (K Units)

Table 64. Europe Respiratory Inhaler Devices Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe Respiratory Inhaler Devices Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe Respiratory Inhaler Devices Sales by Country (2017-2022) & (K Units)

Table 67. Europe Respiratory Inhaler Devices Sales by Country (2023-2028) & (K Units)

Table 68. Europe Respiratory Inhaler Devices Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe Respiratory Inhaler Devices Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific Respiratory Inhaler Devices Sales by Type (2017-2022) & (K Units)

Table 71. Asia Pacific Respiratory Inhaler Devices Sales by Type (2023-2028) & (K Units)

Table 72. Asia Pacific Respiratory Inhaler Devices Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific Respiratory Inhaler Devices Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific Respiratory Inhaler Devices Sales by Application (2017-2022) & (K Units)

Table 75. Asia Pacific Respiratory Inhaler Devices Sales by Application (2023-2028) & (K Units)

Table 76. Asia Pacific Respiratory Inhaler Devices Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific Respiratory Inhaler Devices Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific Respiratory Inhaler Devices Sales by Region (2017-2022) & (K Units)

Table 79. Asia Pacific Respiratory Inhaler Devices Sales by Region (2023-2028) & (K Units)

Table 80. Asia Pacific Respiratory Inhaler Devices Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific Respiratory Inhaler Devices Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America Respiratory Inhaler Devices Sales by Type (2017-2022) & (K Units)

Table 83. Latin America Respiratory Inhaler Devices Sales by Type (2023-2028) & (K Units)

Table 84. Latin America Respiratory Inhaler Devices Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America Respiratory Inhaler Devices Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America Respiratory Inhaler Devices Sales by Application (2017-2022) & (K Units)

Table 87. Latin America Respiratory Inhaler Devices Sales by Application (2023-2028) & (K Units)

Table 88. Latin America Respiratory Inhaler Devices Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America Respiratory Inhaler Devices Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America Respiratory Inhaler Devices Sales by Country (2017-2022) & (K Units)

Table 91. Latin America Respiratory Inhaler Devices Sales by Country (2023-2028) & (K Units)

Table 92. Latin America Respiratory Inhaler Devices Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America Respiratory Inhaler Devices Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa Respiratory Inhaler Devices Sales by Type (2017-2022) & (K Units)

Table 95. Middle East and Africa Respiratory Inhaler Devices Sales by Type (2023-2028) & (K Units)

Table 96. Middle East and Africa Respiratory Inhaler Devices Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa Respiratory Inhaler Devices Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Respiratory Inhaler Devices Sales by Application (2017-2022) & (K Units)

Table 99. Middle East and Africa Respiratory Inhaler Devices Sales by Application (2023-2028) & (K Units)

Table 100. Middle East and Africa Respiratory Inhaler Devices Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Respiratory Inhaler Devices Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Respiratory Inhaler Devices Sales by Country (2017-2022) & (K Units)

Table 103. Middle East and Africa Respiratory Inhaler Devices Sales by Country (2023-2028) & (K Units)

Table 104. Middle East and Africa Respiratory Inhaler Devices Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Respiratory Inhaler Devices Revenue by Country (2023-2028) & (US$ Million)

Table 106. AstraZeneca Corporation Information

Table 107. AstraZeneca Description and Major Businesses

Table 108. AstraZeneca Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 109. AstraZeneca Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. AstraZeneca Recent Developments

Table 111. Beximco Pharmaceuticals Ltd. Corporation Information

Table 112. Beximco Pharmaceuticals Ltd. Description and Major Businesses

Table 113. Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 114. Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Beximco Pharmaceuticals Ltd. Recent Developments

Table 116. Boehringer Ingelheim GmbH Corporation Information

Table 117. Boehringer Ingelheim GmbH Description and Major Businesses

Table 118. Boehringer Ingelheim GmbH Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 119. Boehringer Ingelheim GmbH Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Boehringer Ingelheim GmbH Recent Developments

Table 121. Cipla Ltd. Corporation Information

Table 122. Cipla Ltd. Description and Major Businesses

Table 123. Cipla Ltd. Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 124. Cipla Ltd. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Cipla Ltd. Recent Developments

Table 126. GlaxoSmithKline plc Corporation Information

Table 127. GlaxoSmithKline plc Description and Major Businesses

Table 128. GlaxoSmithKline plc Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 129. GlaxoSmithKline plc Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. GlaxoSmithKline plc Recent Developments

Table 131. Koninklijke Philips N.V. Corporation Information

Table 132. Koninklijke Philips N.V. Description and Major Businesses

Table 133. Koninklijke Philips N.V. Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 134. Koninklijke Philips N.V. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Koninklijke Philips N.V. Recent Developments

Table 136. Merck & Co., Inc. Corporation Information

Table 137. Merck & Co., Inc. Description and Major Businesses

Table 138. Merck & Co., Inc. Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 139. Merck & Co., Inc. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 140. Merck & Co., Inc. Recent Developments

Table 141. OMRON Healthcare Europe B.V. Corporation Information

Table 142. OMRON Healthcare Europe B.V. Description and Major Businesses

Table 143. OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 144. OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 145. OMRON Healthcare Europe B.V. Recent Developments

Table 146. PARI Medical Holding Corporation Information

Table 147. PARI Medical Holding Description and Major Businesses

Table 148. PARI Medical Holding Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 149. PARI Medical Holding Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 150. PARI Medical Holding Recent Developments

Table 151. Teva Pharmaceutical Industries Ltd Corporation Information

Table 152. Teva Pharmaceutical Industries Ltd Description and Major Businesses

Table 153. Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 154. Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Product Model Numbers, Pictures, Descriptions and Specifications

Table 155. Teva Pharmaceutical Industries Ltd Recent Developments

Table 156. Key Raw Materials Lists

Table 157. Raw Materials Key Suppliers Lists

Table 158. Respiratory Inhaler Devices Distributors List

Table 159. Respiratory Inhaler Devices Customers List

Table 160. Respiratory Inhaler Devices Market Trends

Table 161. Respiratory Inhaler Devices Market Drivers

Table 162. Respiratory Inhaler Devices Market Challenges

Table 163. Respiratory Inhaler Devices Market Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Respiratory Inhaler Devices Product Picture

Figure 3. Global Respiratory Inhaler Devices Market Share by Type in 2021 & 2028

Figure 3. Dry Powder Inhaler Product Picture

Figure 4. Metered Dose Inhaler Product Picture

Figure 5. Nebulizer Product Picture

Figure 6. Global Respiratory Inhaler Devices Market Share by Application in 2021 & 2028

Figure 7. Asthma

Figure 8. COPD

Figure 9. Pulmonary Arterial Hypertension

Figure 10. Others Respiratory Disease

Figure 11. Respiratory Inhaler Devices Report Years Considered

Figure 12. Global Respiratory Inhaler Devices Sales 2017-2028 (K Units)

Figure 13. Global Respiratory Inhaler Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 14. Global Respiratory Inhaler Devices Revenue 2017-2028 (US$ Million)

Figure 15. Global Respiratory Inhaler Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 16. Global Respiratory Inhaler Devices Sales Market Share by Region (2017-2022)

Figure 17. Global Respiratory Inhaler Devices Sales Market Share by Region (2023-2028)

Figure 18. North America Respiratory Inhaler Devices Sales YoY (2017-2028) & (K Units)

Figure 19. North America Respiratory Inhaler Devices Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Europe Respiratory Inhaler Devices Sales YoY (2017-2028) & (K Units)

Figure 21. Europe Respiratory Inhaler Devices Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Asia-Pacific Respiratory Inhaler Devices Sales YoY (2017-2028) & (K Units)

Figure 23. Asia-Pacific Respiratory Inhaler Devices Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Latin America Respiratory Inhaler Devices Sales YoY (2017-2028) & (K Units)

Figure 25. Latin America Respiratory Inhaler Devices Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Middle East & Africa Respiratory Inhaler Devices Sales YoY (2017-2028) & (K Units)

Figure 27. Middle East & Africa Respiratory Inhaler Devices Revenue YoY (2017-2028) & (US$ Million)

Figure 28. The Respiratory Inhaler Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 29. The Top 5 and 10 Largest Manufacturers of Respiratory Inhaler Devices in the World: Market Share by Respiratory Inhaler Devices Revenue in 2021

Figure 30. Global Respiratory Inhaler Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 31. Global Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

Figure 32. Global Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

Figure 33. Global Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

Figure 34. Global Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

Figure 35. North America Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

Figure 36. North America Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

Figure 37. North America Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

Figure 38. North America Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

Figure 39. North America Respiratory Inhaler Devices Sales Share by Country (2017-2028)

Figure 40. North America Respiratory Inhaler Devices Revenue Share by Country (2017-2028)

Figure 41. U.S. Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 42. Canada Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 43. Europe Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

Figure 44. Europe Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

Figure 45. Europe Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

Figure 46. Europe Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

Figure 47. Europe Respiratory Inhaler Devices Sales Share by Country (2017-2028)

Figure 48. Europe Respiratory Inhaler Devices Revenue Share by Country (2017-2028)

Figure 49. Germany Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 50. France Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 51. U.K. Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 52. Italy Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 53. Russia Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 54. Asia Pacific Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

Figure 55. Asia Pacific Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

Figure 56. Asia Pacific Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

Figure 57. Asia Pacific Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

Figure 58. Asia Pacific Respiratory Inhaler Devices Sales Share by Region (2017-2028)

Figure 59. Asia Pacific Respiratory Inhaler Devices Revenue Share by Region (2017-2028)

Figure 60. China Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 61. Japan Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 62. South Korea Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 63. India Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 64. Australia Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 65. Taiwan Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 66. Indonesia Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 67. Thailand Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 68. Malaysia Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 69. Philippines Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 70. Latin America Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

Figure 71. Latin America Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

Figure 72. Latin America Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

Figure 73. Latin America Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

Figure 74. Latin America Respiratory Inhaler Devices Sales Share by Country (2017-2028)

Figure 75. Latin America Respiratory Inhaler Devices Revenue Share by Country (2017-2028)

Figure 76. Mexico Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 77. Brazil Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 78. Argentina Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 79. Middle East and Africa Respiratory Inhaler Devices Sales Market Share by Type (2017-2028)

Figure 80. Middle East and Africa Respiratory Inhaler Devices Revenue Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Respiratory Inhaler Devices Sales Market Share by Application (2017-2028)

Figure 82. Middle East and Africa Respiratory Inhaler Devices Revenue Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Respiratory Inhaler Devices Sales Share by Country (2017-2028)

Figure 84. Middle East and Africa Respiratory Inhaler Devices Revenue Share by Country (2017-2028)

Figure 85. Turkey Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 86. Saudi Arabia Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 87. U.A.E Respiratory Inhaler Devices Revenue (2017-2028) & (US$ Million)

Figure 88. Respiratory Inhaler Devices Value Chain

Figure 89. Respiratory Inhaler Devices Production Process

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Respiratory Inhaler Devices Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-19S492

Global Respiratory Inhaler Devices Market Insights, Forecast to 2028

FEATURED COMPANIES

Respiratory Inhaler Devices Market Professional Survey Report

By Type

By Application

By Companies

By Region

FEATURED COMPANIES